Sk Biopharmaceuticals Co Ltd (326030): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 79.400 Won (Südkorea) | 144.100 Won (Südkorea) | 73.000 Won (Südkorea) |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 130.333,336 Won (Südkorea) | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 78.313.250 | - | - |
Kennzahl in 1000 KRW | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 706.740.960,3 | 547.596.283,21 | 354.891.555,52 | 246.179.120,02 | 418.644.529,12 | 25.999.026,72 | 123.852.416,02 | 1.098.738,19 | 85.316.069,95 | 89.927.545,43 |
Herstellungskosten | 42.901.425,17 | 43.100.914,32 | 34.082.497,21 | 37.768.133,59 | 22.335.994,4 | 1.974.010,33 | 514.196,53 | - | 81.744.542,68 | 78.853.360,08 |
Bruttoergebnis | 663.839.535,13 | 504.495.368,89 | 320.809.058,31 | 208.410.986,43 | 396.308.534,72 | 24.025.016,39 | 123.338.219,49 | 1.098.738,19 | 3.571.527,27 | 11.074.185,35 |
▸ Brutto-Marge | 93,93% | 92,13% | 90,4% | 84,66% | 94,66% | 92,41% | 99,58% | 100% | 4,19% | 12,31% |
Betriebliche Aufwendungen | 459.901.064 | 408.155.709 | 358.331.255 | 339.489.015 | 301.350.334 | 263.523.840 | 202.596.956 | 140.202.046 | 101.544.935 | 68.747.707 |
Operativer Gewinn/Verlust | 203.938.471,13 | 96.339.659,89 | -37.522.196,69 | -131.078.028,57 | 94.958.200,72 | -239.498.823,61 | -79.258.736,51 | -139.103.307,81 | -97.973.407,73 | -57.673.521,65 |
▸ Operative Marge | 28,86% | 17,59% | -10,57% | -53,24% | 22,68% | -921,18% | -63,99% | -12.660,28% | -114,84% | -64,13% |
Zinsen (Netto) | -606.073 | -536.324 | 1.037.851 | 3.038.234 | 1.395.929 | -2.341.253 | 236.083 | 1.706.492 | 1.431.704 | 2.273.439 |
▸ Zinsausgaben | 7.690.683 | 10.682.521 | 8.279.609 | 3.716.526 | 946.984 | 4.461.927 | 1.546.820 | 31.491 | - | - |
▸ Zinseinnahmen | 7.084.610 | 10.146.197 | 9.317.460 | 6.754.760 | 2.342.913 | 2.120.674 | 1.782.903 | 1.737.983 | 1.431.704 | 2.273.439 |
Andere Ausgaben | 52.448.140,18 | 23.207.579,74 | 7.373.416,93 | 14.429.069,38 | 25.077.581,49 | -1.930.747,2 | 5.428.415,64 | 241.955,19 | 267.774,27 | -25.039.239,65 |
Gewinn vor Steuern | 150.884.257,95 | 72.595.756,15 | -43.857.762,62 | -142.468.863,95 | 71.276.548,23 | -239.909.329,41 | -84.451.069,15 | -137.638.771 | -96.809.478 | -30.360.843 |
Steueraufwand | - | - | - | -3.037.986,27 | 6.430.907,91 | 7.504.284,45 | -12.931.602,33 | 583.198,87 | 627.297,95 | - |
Minderheitenanteil | -116.066.239,85 | -168.142.281,72 | -10.974.913,38 | 0,32 | 0,32 | 0,14 | -0,53 | -125.492,11 | 212.282,82 | - |
Nettogewinn/-verlust | 266.950.497,8 | 240.738.037,87 | -32.882.849,24 | -139.430.878 | 64.845.640 | -247.413.614 | -71.519.466,29 | -138.096.477,76 | -97.649.058,77 | -30.360.843 |
▸ Netto-Marge | 37,77% | 43,96% | -9,27% | -56,64% | 15,49% | -951,63% | -57,75% | -12.568,64% | -114,46% | -33,76% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.